May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Cristina P. Matos(University of Lisbon), Ceyda Açılan(Koç University), Isabel Correia(University of Lisbon), Maria Deus Carvalho(University of Lisbon), Fernando R. Pavan(Universidade Estadual Paulista (Unesp)), Özge Çevik(Adnan Menderes University), Ana Isabel Tomaz(Instituto Superior Técnico), Liliana P. Ferreira(University of Lisbon), João Costa Pessoa(University of Lisbon), M. Helena García(Université Claude Bernard Lyon 1), Patrique Nunes(University of Lisbon), Tugba Bagcı-Önder(Koç University), Buse Cevatemre(Bursa Uludağ Üni̇versi̇tesi̇), Zelal Adıgüzel(Türkiye Bilimsel ve Teknolojik Araştırma Kurumu), Débora L. Campos(Universidade Estadual Paulista (Unesp)), Yasemin Yıldızhan(Türkiye Bilimsel ve Teknolojik Araştırma Kurumu)
Cited by 45
Related Papers
Apoptosis: why and how does it occur in biology?
|Cell Biochemistry and Function|2011|227
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis
|Nature Cell Biology|2022|130
Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents
|Biochimica et Biophysica Acta (BBA) - General Subjects|2016|90
DNA repair pathways involved in anaphase bridge formation
|Genes Chromosomes and Cancer|2007|63